161 related articles for article (PubMed ID: 30471863)
1. Overexpressing kringle 1 domain of hepatocyte growth factor with adeno-associated virus inhibits the pathological retinal neovascularization in an oxygen-induced retinopathy mouse model.
Sun P; Liu Z
Biochem Biophys Res Commun; 2019 Jan; 508(1):130-137. PubMed ID: 30471863
[TBL] [Abstract][Full Text] [Related]
2. The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma.
Shen Z; Yang ZF; Gao Y; Li JC; Chen HX; Liu CC; Poon RT; Fan ST; Luk JM; Sze KH; Li TP; Gan RB; He ML; Kung HF; Lin MC
Cancer Res; 2008 Jan; 68(2):404-14. PubMed ID: 18199534
[TBL] [Abstract][Full Text] [Related]
3. A novel and effective human hepatocyte growth factor kringle 1 domain inhibits ocular neovascularization.
Lu Q; Zhang L; Shen X; Zhu Y; Zhang Q; Zhou Q; Gan R; Zhang H; Zhong Y; Xie B
Exp Eye Res; 2012 Dec; 105():15-20. PubMed ID: 23085338
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus-mediated expression of vascular endothelial growth factor peptides inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Deng WT; Yan Z; Dinculescu A; Pang J; Teusner JT; Cortez NG; Berns KI; Hauswirth WW
Hum Gene Ther; 2005 Nov; 16(11):1247-54. PubMed ID: 16259558
[TBL] [Abstract][Full Text] [Related]
5. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of 15-lipoxygenase-1 in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via downregulation of vascular endothelial growth factor-A expression.
Li Z; He T; Du K; Xing YQ; Yan Y; Chen Z; Zhang H; Shen Y
Mol Vis; 2012; 18():2847-59. PubMed ID: 23233787
[TBL] [Abstract][Full Text] [Related]
7. AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer.
Nie B; Shen Z; Wen JB; Wong OG; Hsueh WD; Huo LF; Kung HF; Jiang B; Lin MC
Mol Cancer Ther; 2008 Sep; 7(9):2855-65. PubMed ID: 18790766
[TBL] [Abstract][Full Text] [Related]
8. A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma.
Shen Z; Wong OG; Yao RY; Liang J; Kung HF; Lin MC
Cancer Lett; 2008 Dec; 272(2):268-76. PubMed ID: 18722051
[TBL] [Abstract][Full Text] [Related]
9. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
[TBL] [Abstract][Full Text] [Related]
10. Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy.
Rakoczy PE; Brankov M; Fonceca A; Zaknich T; Rae BC; Lai CM
Diabetes; 2003 Mar; 52(3):857-63. PubMed ID: 12606531
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.
Al-Shabrawey M; Bartoli M; El-Remessy AB; Platt DH; Matragoon S; Behzadian MA; Caldwell RW; Caldwell RB
Am J Pathol; 2005 Aug; 167(2):599-607. PubMed ID: 16049343
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization.
Raisler BJ; Berns KI; Grant MB; Beliaev D; Hauswirth WW
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8909-14. PubMed ID: 12072560
[TBL] [Abstract][Full Text] [Related]
13. Heparanase and vascular endothelial growth factor expression is increased in hypoxia-induced retinal neovascularization.
Hu J; Song X; He YQ; Freeman C; Parish CR; Yuan L; Yu H; Tang S
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6810-7. PubMed ID: 22956610
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.
Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
16. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
17. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
Song HB; Jun HO; Kim JH; Fruttiger M; Kim JH
Cell Calcium; 2015 Feb; 57(2):101-8. PubMed ID: 25605522
[TBL] [Abstract][Full Text] [Related]
18. GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis.
Xu X; Ding X; Wang Z; Ye S; Xu J; Liang Z; Luo R; Xu J; Li X; Ren Z
Microvasc Res; 2024 Jul; 154():104689. PubMed ID: 38636926
[TBL] [Abstract][Full Text] [Related]
19. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP.
Miyamoto N; Mandai M; Takagi H; Suzuma I; Suzuma K; Koyama S; Otani A; Oh H; Honda Y
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2007-14. PubMed ID: 12037012
[TBL] [Abstract][Full Text] [Related]
20. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
